Laryngoscope Investigative Otolaryngology

Papers
(The H4-Index of Laryngoscope Investigative Otolaryngology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Comparing cadaveric and 3D‐printed laryngeal models in transcutaneous injection laryngoplasty90
Goiter surgery recommendations in sub‐Saharan Africa in humanitarian cooperation45
Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland33
Otolaryngology Workforce Projections in the United States, 2021–203633
Malignant otitis externa: What is the role of surgery?30
No‐Shows in a Tertiary Care Pediatric Otolaryngology Clinic: Predictors and Impact on Provider Productivity29
Improved nasal recovery and intact olfactory function after a transseptal approach for endoscopic endonasal transsphenoidal adenomectomy: A retrospective analysis24
Prognostic values of systemic inflammation and nutrition‐based prognostic indices in oropharyngeal carcinoma22
A nomogram for predicting overall survival of patients with sinonasal melanoma: A population‐based study21
Cochlear Implantation: Electrode Impedance in Users With Triphasic Pulse Pattern20
Disparities in the Receipt of Immunotherapy for Patients With Head and Neck Mucosal Melanoma19
An Atypical Anatomical Variation in Facial Nerve Position: Temporal Branch Lateral and Main Trunk Medial to the Retromandibular Vein in a Series of Three Cadaveric Cases With Clinical Implications18
Differences in pharyngeal swallow event timing: Healthy aging, Parkinson disease, and amyotrophic lateral sclerosis17
The State of Exercise‐Based Dysphagia Intervention in the Literature: A Scoping Review17
Computational fluid dynamics of upper airway aerodynamics for exercise‐induced laryngeal obstruction: A feasibility study17
Modified individualized titanium mesh in orbital floor reconstruction for preventing exposure16
Pre‐clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization16
0.12049007415771